| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Penny F Whiting, Robert F Wolff, Sohan Deshpande, Marcello Di Nisio, Steven Duffy, Adrian V Hernandez, J Christiaan Keurentjes, Shona Lang, Kate Misso, Steve Ryder, Simone Schmidlkofer, Marie Westwood, Jos Kleijne. Cannabinoids for Medical Use: A Systematic Review and Meta-analysis. JAMA. vol 313. issue 24. 2015-07-02. PMID:26103030. |
cannabis and cannabinoid drugs are widely used to treat disease or alleviate symptoms, but their efficacy for specific indications is not clear. |
2015-07-02 |
2023-08-13 |
Not clear |
| Ryan Vandrey, Jeffrey C Raber, Mark E Raber, Brad Douglass, Cameron Miller, Marcel O Bonn-Mille. Cannabinoid Dose and Label Accuracy in Edible Medical Cannabis Products. JAMA. vol 313. issue 24. 2015-07-02. PMID:26103034. |
cannabinoid dose and label accuracy in edible medical cannabis products. |
2015-07-02 |
2023-08-13 |
Not clear |
| Oier Aizpurua-Olaizola, Jone Omar, Patricia Navarro, Maitane Olivares, Nestor Etxebarria, Aresatz Usobiag. Identification and quantification of cannabinoids in Cannabis sativa L. plants by high performance liquid chromatography-mass spectrometry. Analytical and bioanalytical chemistry. vol 406. issue 29. 2015-07-01. PMID:25338935. |
identification and quantification of cannabinoids in cannabis sativa l. plants by high performance liquid chromatography-mass spectrometry. |
2015-07-01 |
2023-08-13 |
Not clear |
| Oier Aizpurua-Olaizola, Jone Omar, Patricia Navarro, Maitane Olivares, Nestor Etxebarria, Aresatz Usobiag. Identification and quantification of cannabinoids in Cannabis sativa L. plants by high performance liquid chromatography-mass spectrometry. Analytical and bioanalytical chemistry. vol 406. issue 29. 2015-07-01. PMID:25338935. |
high performance liquid chromatography tandem mass spectrometry (hplc-ms/ms) has been successfully applied to cannabis plant extracts in order to identify cannabinoid compounds after their quantitative isolation by means of supercritical fluid extraction (sfe). |
2015-07-01 |
2023-08-13 |
Not clear |
| Oier Aizpurua-Olaizola, Jone Omar, Patricia Navarro, Maitane Olivares, Nestor Etxebarria, Aresatz Usobiag. Identification and quantification of cannabinoids in Cannabis sativa L. plants by high performance liquid chromatography-mass spectrometry. Analytical and bioanalytical chemistry. vol 406. issue 29. 2015-07-01. PMID:25338935. |
six major cannabinoids [tetrahydrocannabinolic acid (thca), tetrahydrocannabinol (thc), cannabidiol (cbd), tetrahydrocannabivarin (thcv), cannabigerol (cbg), and cannabinol (cbn)] were quantified (rsd < 10%), and seven more cannabinoids were identified and verified by means of a liquid chromatograph coupled to a quadrupole-time-of-flight (q-tof) detector. |
2015-07-01 |
2023-08-13 |
Not clear |
| Oier Aizpurua-Olaizola, Jone Omar, Patricia Navarro, Maitane Olivares, Nestor Etxebarria, Aresatz Usobiag. Identification and quantification of cannabinoids in Cannabis sativa L. plants by high performance liquid chromatography-mass spectrometry. Analytical and bioanalytical chemistry. vol 406. issue 29. 2015-07-01. PMID:25338935. |
finally, based on the distribution of the analyzed cannabinoids in 30 cannabis sativa l. plant varieties and the principal component analysis (pca) of the resulting data, a clear difference was observed between outdoor and indoor grown plants, which was attributed to a higher concentration of thc, cbn, and cbd in outdoor grown plants. |
2015-07-01 |
2023-08-13 |
Not clear |
| David W Volk, Stephen M Eggan, Andrew G Horti, Dean F Wong, David A Lewi. Reciprocal alterations in cortical cannabinoid receptor 1 binding relative to protein immunoreactivity and transcript levels in schizophrenia. Schizophrenia research. vol 159. issue 1. 2015-06-22. PMID:25107849. |
the deleterious effects of cannabis use in schizophrenia have been linked, in part, to underlying disturbances in endogenous cannabinoid signaling in the prefrontal cortex. |
2015-06-22 |
2023-08-13 |
human |
| Philip W Lam, David W Fros. Nabilone therapy for cannabis withdrawal presenting as protracted nausea and vomiting. BMJ case reports. vol 2014. 2015-06-22. PMID:25246463. |
there is growing evidence that supports the use of plant-derived and synthetic cannabinoids for the treatment of cannabis withdrawal. |
2015-06-22 |
2023-08-13 |
Not clear |
| Michael B Gatch, Michael J Forste. Δ9-Tetrahydrocannabinol-like discriminative stimulus effects of compounds commonly found in K2/Spice. Behavioural pharmacology. vol 25. issue 8. 2015-06-22. PMID:25325289. |
a number of cannabinoid compounds are being sold in the form of incense as 'legal' alternatives to marijuana. |
2015-06-22 |
2023-08-13 |
mouse |
| Michael B Gatch, Michael J Forste. Δ9-Tetrahydrocannabinol-like discriminative stimulus effects of compounds commonly found in K2/Spice. Behavioural pharmacology. vol 25. issue 8. 2015-06-22. PMID:25325289. |
several of the most commonly used synthetic cannabinoids produce behavioral effects comparable with those of Δ-thc, which suggests that these compounds may share the psychoactive effects of marijuana responsible for abuse liability. |
2015-06-22 |
2023-08-13 |
mouse |
| Matthew N Newmeyer, Nathalie A Desrosiers, Dayong Lee, Damodara R Mendu, Allan J Barnes, David A Gorelick, Marilyn A Huesti. Cannabinoid disposition in oral fluid after controlled cannabis smoking in frequent and occasional smokers. Drug testing and analysis. vol 6. issue 10. 2015-06-19. PMID:24652685. |
cannabinoid disposition in oral fluid after controlled cannabis smoking in frequent and occasional smokers. |
2015-06-19 |
2023-08-12 |
Not clear |
| Matthew N Newmeyer, Nathalie A Desrosiers, Dayong Lee, Damodara R Mendu, Allan J Barnes, David A Gorelick, Marilyn A Huesti. Cannabinoid disposition in oral fluid after controlled cannabis smoking in frequent and occasional smokers. Drug testing and analysis. vol 6. issue 10. 2015-06-19. PMID:24652685. |
after controlled smoking of a 6.8% Δ(9) -tetrahydrocannabinol (thc) cannabis cigarette by frequent and occasional smokers, of was collected with the oral-eze device for up to 30 h. samples were analyzed for multiple cannabinoids by a validated 2d-gc-ms method. |
2015-06-19 |
2023-08-12 |
Not clear |
| Matthew N Newmeyer, Nathalie A Desrosiers, Dayong Lee, Damodara R Mendu, Allan J Barnes, David A Gorelick, Marilyn A Huesti. Cannabinoid disposition in oral fluid after controlled cannabis smoking in frequent and occasional smokers. Drug testing and analysis. vol 6. issue 10. 2015-06-19. PMID:24652685. |
our data illustrate the effectiveness of the oral-eze® device for of collection, the impact of self-administered smoked cannabis history on of cannabinoid results, and the ability to improve interpretation and tailor of cannabinoid cut-offs to fulfill the detection window needs of a given program. |
2015-06-19 |
2023-08-12 |
Not clear |
| b' Rosa Ruchlemer, Michal Amit-Kohn, David Raveh, Lum\\xc3\\xadr Hanu\\xc5\\xa. Inhaled medicinal cannabis and the immunocompromised patient. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. vol 23. issue 3. 2015-06-17. PMID:25216851.' |
we describe the results of culturing the cannabis herb, three methods of sterilization, and the measured loss of a main cannabinoid compound activity. |
2015-06-17 |
2023-08-13 |
Not clear |
| b' Aleksandar Damjanovi\\xc4\\x87, Maja Pantovi\\xc4\\x87, Aleksandra Damjanovi\\xc4\\x87, Bojana Dunji\\xc4\\x87-Kosti\\xc4\\x87, Maja Ivkovi\\xc4\\x87, Sr\\xc4\\x91an Milovanovi\\xc4\\x87, Maja Lackovi\\xc4\\x87, Ivan Dimitrijevi\\xc4\\x8. Cannabis and psychosis revisited. Psychiatria Danubina. vol 27. issue 1. 2015-06-12. PMID:25751443.' |
the association between cannabinoids and psychosis has been known for almost a thousand years, but it is still speculated whether cannabis use may be a contributory cause of psychosis, that is, whether it may precipitate schizophrenia in those at risk. |
2015-06-12 |
2023-08-13 |
Not clear |
| Jessica Margaret Sido, Xiaoming Yang, Prakash S Nagarkatti, Mitzi Nagarkatt. Δ9-Tetrahydrocannabinol-mediated epigenetic modifications elicit myeloid-derived suppressor cell activation via STAT3/S100A8. Journal of leukocyte biology. vol 97. issue 4. 2015-06-11. PMID:25713087. |
we recently demonstrated that marijuana cannabinoids are potent inducers of mdscs. |
2015-06-11 |
2023-08-13 |
mouse |
| Diana Felton, Naamah Zitomersky, Shannon Manzi, Jenifer R Lightdal. 13-year-old girl with recurrent, episodic, persistent vomiting: out of the pot and into the fire. Pediatrics. vol 135. issue 4. 2015-06-11. PMID:25733759. |
severe vomiting with chronic cannabis use, known as cannabinoid hyperemesis syndrome, has recently been more widely recognized as an etiology of persistent episodic vomiting. |
2015-06-11 |
2023-08-13 |
Not clear |
| Futoshi Taura, Miu Iijima, Jung-Bum Lee, Toshihiro Hashimoto, Yoshinori Asakawa, Fumiya Kurosak. Daurichromenic acid-producing oxidocyclase in the young leaves of Rhododendron dauricum. Natural product communications. vol 9. issue 9. 2015-06-11. PMID:25918805. |
interestingly, these catalytic properties of dca synthase are quite similar to those reported for cannabinoid synthases in the marijuana plant cannabis sativa l. |
2015-06-11 |
2023-08-13 |
Not clear |
| Ryuichi Murase, Rumi Kawamura, Eric Singer, Arash Pakdel, Pranamee Sarma, Jonathon Judkins, Eiman Elwakeel, Sonali Dayal, Esther Martinez-Martinez, Mukkanti Amere, Ramesh Gujjar, Anu Mahadevan, Pierre-Yves Desprez, Sean D McAlliste. Targeting multiple cannabinoid anti-tumour pathways with a resorcinol derivative leads to inhibition of advanced stages of breast cancer. British journal of pharmacology. vol 171. issue 19. 2015-06-09. PMID:24910342. |
the psychoactive cannabinoid Δ(9) -tetrahydrocannabinol (thc) and the non-psychoactive cannabinoid cannabidiol (cbd) can both reduce cancer progression, each through distinct anti-tumour pathways. |
2015-06-09 |
2023-08-13 |
Not clear |
| Ornelio Rosati, Federica Messina, Azzurra Pelosi, Massimo Curini, Vanessa Petrucci, Jürg Gertsch, Andrea Chicc. One-pot heterogeneous synthesis of Δ(3)-tetrahydrocannabinol analogues and xanthenes showing differential binding to CB(1) and CB(2) receptors. European journal of medicinal chemistry. vol 85. 2015-06-02. PMID:25072877. |
Δ(9)-tetrahydrocannabinol (Δ(9)-thc) is the major psychoactive cannabinoid in hemp (cannabis sativa l.) and responsible for many of the pharmacological effects mediated via cannabinoid receptors. |
2015-06-02 |
2023-08-13 |
Not clear |